Stockscreener 앱 받기
7.85
1.03%
0.08
시간 외 거래:
7.85
전일 마감가:
$7.77
열려 있는:
$7.62
하루 거래량:
1.76M
Relative Volume:
0.94
시가총액:
$1.11B
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
13.78
EPS:
0.5695
순현금흐름:
$60.67M
1주 성능:
+10.41%
1개월 성능:
-0.51%
6개월 성능:
-12.49%
1년 성능:
+13.77%
1일 변동 폭
$7.61
$7.93
1주일 범위
$7.08
$7.93
52주 변동 폭
$4.52
$11.55
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
(MRVI) Investment Analysis and Advice - Stock Traders Daily
MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com
Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (MRVI) to Release Earnings on Thursday - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 7%Still a Buy? - MarketBeat
Millennium Management LLC Adjusts Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com
Where Do Analysts See Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Heading? - Stocks Register
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $10.67 Average PT from Brokerages - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Moderate Buy” by Analysts - Defense World
(MRVI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.6%Here's Why - MarketBeat
43,372 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Bought by The Manufacturers Life Insurance Company - Defense World
Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 - GlobeNewswire
Maravai LifeSciences Holdings Inc (MRVI) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet? - Simply Wall St
Long Term Trading Analysis for (MRVI) - Stock Traders Daily
The Attractiveness of Investing In Maravai LifeSciences Holdings Inc (MRVI) is Growing - Knox Daily
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Sei Investments Co. - Defense World
Maravai Lifesciences (MRVI) Stock Surges Over 5% Amid Strong Buy Recommendations - GuruFocus.com
Maravai LifeSciences Holdings Inc [MRVI] stock for 97,570,660 USD was sold by GTCR INVESTMENT XI LLC - Knox Daily
Dimensional Fund Advisors LP Lowers Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Its Stock Has Paid Off Big Time For Maravai LifeSciences Holdings Inc - SETE News
RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter - Insider Monkey
Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga
Investing in Maravai LifeSciences Holdings Inc (MRVI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Maravai LifeSciences (NASDAQ:MRVI) Price Target Lowered to $7.00 at The Goldman Sachs Group - MarketBeat
Balance Sheet Breakdown: Maravai LifeSciences Holdings Inc (MRVI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Maravai LifeSciences Holdings Inc (MRVI) may enjoy gains as insiders got busy in the recent days - Knox Daily
Clearbridge Investments LLC Has $7.55 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
10 Best Biotech Stocks To Buy Under $20 - Insider Monkey
150,878 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Acquired by Algert Global LLC - MarketBeat
Maravai LifeSciences Holdings Inc [MRVI] Records 50-Day SMA of $8.79 - Knox Daily
Squarepoint Ops LLC Acquires 229,421 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Brokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Price Target at $10.78 - MarketBeat
Point72 Asia Singapore Pte. Ltd. Purchases Shares of 4,449 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Millennium Management LLC Has $42.74 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com
Maravai LifeSciences Holdings Inc (MRVI) stock analysis: A simple moving average approach - US Post News
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences - Yahoo Finance
Cubist Systematic Strategies LLC Has $2.03 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences' SWOT analysis: stock outlook amid mRNA transition - Investing.com India
Monitoring Maravai LifeSciences Holdings Inc (MRVI) after recent insider movements - Knox Daily
Ready to Jump After Recent Trade: Maravai LifeSciences Holdings Inc (MRVI) - SETE News
Maravai LifeSciences' SWOT analysis: stock outlook amid mRNA transition By Investing.com - Investing.com South Africa
Systematic Financial Management LP Reduces Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Mackenzie Financial Corp Grows Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Point72 Asset Management L.P. Buys 2,109,199 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences Holdings Inc [MRVI] Director makes an insider purchase of 9,940,974 shares worth 97.57 million. - Knox Daily
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):